Tanshinone IIA activates calcium-dependent apoptosis signaling pathway in human hepatoma cells
Zhi-Kai Dai1, Jiang-Ke Qin, Jiao-E Huang
1Department of Pharmacology, Pharmaceutical Institute of Guilin Medical University, 541004 Guilin, China.
Abstract:
Tanshinone IIA (Tan IIA), a natural product from herb Salvia miltiorrhiza Bunge, has potential anti-tumor activity. The aim of this study was to pinpoint the molecular mechanisms underlying Tan IIA-induced cancer cell apoptosis. Human hepatoma BEL-7402 cells treated with Tan IIA underwent assessment with MTT assay for cell viability, 10-day culture for colony formation, flow cytometry and fluorescence microscopy for apoptosis and cell cycle analysis. Changes in intracellular [Ca(2+)] and mitochondrial membrane potential (∆ψ) reflected the calcium-dependent apoptosis pathway. RT-PCR was used to detect gene expression of Bad and metallothionein 1A (MT 1A). Cytotoxicity of Tan IIA was tested in human amniotic mesenchymal stem cells (HAMCs). Tan IIA exhibited dose-dependent and time-dependent anticancer effects on BEL-7402 cells through apoptosis and G(0)/G(1) arrest. Cells treated with Tan IIA increased their intracellular calcium, decreased their mitochondrial membrane potential and induced Bad and MT 1A mRNA expression. No adverse effects of Tan IIA were found in HAMCs. In conclusion, these results indicate that Tan IIA-induced cancer cell apoptosis acts via activation of calcium-dependent apoptosis signaling pathways and upregulation of MT 1A expression.
Insights
Tanshinone IIA (Tan IIA) from Salvia miltiorrhiza induces cancer cell death by activating calcium-dependent pathways and upregulating MT 1A. This natural compound shows anticancer potential without harming stem cells.
Area of Science:
- Pharmacology
- Molecular Biology
- Cancer Research
Background:
- Tanshinone IIA (Tan IIA), a natural product derived from Salvia miltiorrhiza Bunge, exhibits promising anti-tumor properties.
- Understanding the precise molecular mechanisms of Tan IIA's action is crucial for its therapeutic development.
Purpose of the Study:
- To elucidate the molecular pathways involved in Tan IIA-induced apoptosis in cancer cells.
- To evaluate the safety profile of Tan IIA in human amniotic mesenchymal stem cells (HAMCs).
Main Methods:
- Human hepatoma BEL-7402 cells were treated with Tan IIA and analyzed for viability (MTT assay), colony formation, apoptosis, and cell cycle progression (flow cytometry, fluorescence microscopy).
- Intracellular calcium levels and mitochondrial membrane potential (∆ψ) were measured.
- Gene expression of Bad and metallothionein 1A (MT 1A) was assessed using RT-PCR.
Main Results:
- Tan IIA demonstrated dose- and time-dependent anticancer effects on BEL-7402 cells, inducing apoptosis and G(0)/G(1) cell cycle arrest.
- Tan IIA treatment led to increased intracellular calcium, decreased mitochondrial membrane potential, and elevated Bad and MT 1A mRNA expression.
- No cytotoxic effects were observed in HAMCs, indicating a favorable safety profile.
Conclusions:
- Tan IIA-induced cancer cell apoptosis is mediated by the activation of calcium-dependent signaling pathways.
- Upregulation of metallothionein 1A (MT 1A) expression is implicated in the anti-cancer mechanism of Tan IIA.
- Tan IIA presents a potential therapeutic agent with selective toxicity towards cancer cells and safety in stem cells.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
TGF - β Signaling Pathway
The JAK-STAT Signaling Pathway
Cellular Injury V: Apoptosis and Autophagy
